BioCentury
ARTICLE | Financial News

Stemline completes IPO

February 4, 2013 8:00 AM UTC

Stemline Therapeutics Inc. (NASDAQ:STML), New York, N.Y. Business: Cancer Date completed: 1/28/13 Type: IPO Raised: $38.2 million Shares: 3.8 million Price: $10 Shares after offering: 7.5 million Unde...